Merck enters five-year agreement to provide end-to-end testing services for Genetix Biotherapeutics' commercial therapiesPartnership builds on ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a five-year agreement with Genetix ...
Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.
Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
Motif Neurotech wins FDA clearance for first human trial of a wireless brain implant targeting treatment-resistant depression ...
In the wake of recent government policy aimed at actively replacing animal models in drug discovery, we consider a possible ...
Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing technologies, is pleased to announce that its ...
A2LA-accredited Irvine lab explains why accredited vs. self-declared compliance determines COA acceptance by Amazon, retailers, and FDA. IRVINE, CA, UNITED STATES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results